Portosystemic shunt placement reveals blood signatures for the development of hepatic encephalopathy through mass spectrometry

18Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Elective transjugular intrahepatic portosystemic shunt (TIPS) placement can worsen cognitive dysfunction in hepatic encephalopathy (HE) patients due to toxins, including possible microbial metabolites, entering the systemic circulation. We conducted untargeted metabolomics on a prospective cohort of 22 patients with cirrhosis undergoing elective TIPS placement and followed them up to one year post TIPS for HE development. Here we suggest that pre-existing intrahepatic shunting predicts HE severity post-TIPS. Bile acid levels decrease in the peripheral vein post-TIPS, and the abundances of three specific conjugated di- and tri-hydroxylated bile acids are inversely correlated with HE grade. Bilirubins and glycerophosphocholines undergo chemical modifications pre- to post-TIPS and based on HE grade. Our results suggest that TIPS-induced metabolome changes can impact HE development, and that pre-existing intrahepatic shunting could be used to predict HE severity post-TIPS.

Cite

CITATION STYLE

APA

Dantas Machado, A. C., Ramos, S. F., Gauglitz, J. M., Fassler, A. M., Petras, D., Aksenov, A. A., … Zarrinpar, A. (2023). Portosystemic shunt placement reveals blood signatures for the development of hepatic encephalopathy through mass spectrometry. Nature Communications , 14(1). https://doi.org/10.1038/s41467-023-40741-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free